StonvexLoading…
StonvexStonvexStonvexCore line items from AVY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $2.30B | $8.86B | $6.58B | $4.37B |
Operating Income | $240.40M | $925.10M | $717.30M | $482.50M |
Net Income | $168.10M | $688.00M | $521.60M | $355.30M |
EPS (Diluted) | $2.18 | $8.79 | $6.64 | $4.50 |
Total Assets | $8.98B | $8.80B | $8.87B | $8.57B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $255.10M | $202.80M | $536.30M | $215.90M |
Free Cash Flow OCF − CapEx | $108.20M | $712.40M | $402.70M | $126.50M |
Shares Outstanding | 76.66M | 76.88M | 77.55M | 78.04M |